307 results found for 'C-S4CS-2308 Schulungsunterlagen 🛌 C-S4CS-2308 Trainingsunterlagen 🧷 C-S4CS-2308 Schulungsunterlagen 🕵 Suchen Sie einfach auf ➥ www.itzert.com 🡄 nach kostenloser Download von 《 C-S4CS-2308 》 ☣C-S4CS-2308 Prüfungsfragen'.
Overlooked No More: Access to TB Innovations for Children and Pregnant Women is a Must
News | 19 March 2024
...toxic treatment options for all people with drug-resistant TB, including children, pregnant women and people with common co-morbidities. If recommended by WHO, four new all-oral regimens for multidrug-resistant (MDR) TB...
Countdown to 2030: Stronger alignment for country impact
News | 23 May 2024
...in 69 countries. Country case studies in the report, illustrate how the commitment to stronger collaboration is being translated into reality at country level. This fifth progress report amplifies countries’...
Unitaid renews call for clear access strategy after positive results from Gilead’s PURPOSE 2 lenacapavir trial
News | 13 September 2024
...of research have yet to deliver an effective vaccine. Beyond prevention, it also holds promise for long-acting HIV treatment, pending further evidence on suitable combination therapies. Communities and countries most...
New Child-Friendly Formulation of Rifapentine for Short Course Tuberculosis Prevention Treatment Now Available as Unitaid and IMPAACT4TB Launch an Early Market Access Vehicle
News | 11 December 2023
...more information and media requests: Hervé Verhoosel Head of Communications and Spokesperson M: +33 6 22 59 73 54 verhooselh@unitaid.who.int Kyle Wilkinson, Communications Officer +41 79 445 17 45 wilkinsonk@unitaid.who.int...
Japan commits US$7.3 million to Unitaid to strengthen access to lifesaving medical oxygen in Kenya and Tanzania
News | 18 March 2024
...oxygen for all patients who need it is a key component of a strong health system.” Medical oxygen is a lifesaving medicine with no substitute. It is essential for surgery,...
Unitaid applauds France’s steadfast commitment to sustainable global health interventions
News | 21 June 2024
At the Global Forum for Vaccine Sovereignty and Innovation held in Paris on 20 June, French President Emanuel Macron reconfirmed his country’s commitment to the innovative financing model that helped...
WHO recommendations, supported by Unitaid clinical trials, now allow for better treatment for all people with drug-resistant TB, including children and pregnant women
News | 23 August 2024
...IRD support local drug-resistant TB treatment activities. Each experimental regimen included at least one new drug combined with up to four companion drugs. The control regimen followed the local standard...
Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest
News | 29 September 2023
Open letter from Unitaid’s Executive Director calls on the drug company to drop secondary patents for the drug-resistant TB (DR-TB) medicine bedaquiline, and to make negotiated rates available to all...
Partners announce reduced price for patient-friendly tuberculosis preventive treatments
News | 01 August 2022
...complete the full treatment cycle. A 2021 study showed that 90 percent of patients prescribed 3HP completed treatment compared to 50 percent of patients prescribed isoniazid alone[1]. Access to TPT...
Ahead of World TB Day, Unitaid and FIND welcome WHO resources to accelerate access to faster, more accurate tests for drug-resistant tuberculosis
News | 21 March 2024
...Hervé Verhoosel Head of Communications and Spokesperson, Unitaid M: +33 6 22 59 73 54 verhooselh@unitaid.who.int Sarah-Jane Loveday Director, Communications, UNFPA M: +41 79 431 62 44 media@finddx.org About Unitaid...